How common is ventilator-associated pneumonia after coronavirus disease 2019?

ABSTRACT:

Purpose of review

The first studies on COVID-19 patients with acute respiratory distress syndrome (ARDS) described a high rate of secondary bacterial ventilator-associated pneumonia (VAP). The specificity of VAP diagnoses in these patients are reviewed, including their actual rate.

Recent findings

Published studies described high rates of bacterial VAP among COVID-19 patients with ARDS, and these VAP episodes are usually severe and of specifically poor prognosis with high mortality. Indeed, Severe acute respiratory syndrome - coronavirus disease 19 (SARS-CoV2) infection elicits alterations that may explain a high risk of VAP. In addition, breaches in the aseptic management of patients might have occurred when the burden of care was heavy. In addition, VAP in these patients i

SUBMITTER: Wicky PH 

PROVIDER: S-EPMC8900889 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature